Please login to the form below

Video: Global Biosimilars Market

Research director of Therapy Watch, Laurent Chanroux, discusses the growth opportunities for biosimilars and the importance of adaptable market tracking for pre and post product launch

It is predicted that biosimilars will provide the opportunity for significant cost savings within the biogenic market, such as sustainability for national healthcare systems and improving access to innovative and expansive drugs. In this video, director Laurent Chanroux uses data taken from our Therapy Watch RA study, to discuss the predicted impact that biosimilars are likely to make and the importance of having a market research partner who can adapt their market tracking to produce robust forecasts for your product.

Watch the video: 
http://www.researchpartnership.com/news/2016/03/video-global-biosimilars-market/utm_source=Research...

16th May 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Healthcare in the age of AI: How will artificial intelligence impact future decision-making?
Authored by: Constanza Salas, Jhon Galindo and Rachel Howard
Research Partnership
Therapy Watch launches new tracker covering Postpartum Depression
The new Therapy Watch Postpartum depression (PPD) study is the first tracker in the series to cover Psychiatry
Research Partnership
Value-based pricing reform: Strengthening the ‘front door’ to the Colombian pharmaceutical market
Authored by: Marc Garcia and Tania Rodrigues
Research Partnership
Infographic: Rare Diseases in China
How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.
Research Partnership
New syndicated COPD report now available
Living with COPD 2023
Research Partnership
Man vs microbe: the fight against antimicrobial resistance
How the emerging resistance to antibiotics is being exacerbated by a lack of research and development into new antibiotics.
Research Partnership